>Indeed PFE has not shown any, or hardly any interest in generics up to present, but in my extremely humble opinion this is a venue PFE should seriously consider, and will in fact make their significant entry to generics by acquisition.<
Do have any information, however sketchy, that PFE will move in this direction? T.i.a.
Market Data 
Markets 
AI
